Surgery

The Kala Pharmaceuticals therapy INVELTYS becomes the first twice-daily ocular corticosteroid indicated for such treatment.

The SPRINT endura and extensa are cleared for both chronic and acute pain including post-operative pain and post-traumatic pain.

The 30-person panel, including physicians and patients, recommended a median 12.5 tablets of 5mg opioid for 20 common procedures.

In a systematic review and meta-analysis, low-quality drugs are most prevalent low- to middle-income countries, and can cost up to $200 billion annually.

How researchers are using stem cells and a greater patient population to improve on the invasive methods used to treat the common women's disease.

The Cleveland Clinic’s pioneer of minority programs plans to end health disparity.

Analysis of data from the Danish Birth Registry showed that tonsillectomies were associated with nearly triple relative risk of disease of the respiratory tract.

An analysis of pediatric ICU interactions found that physicians are far more likely to get a beneficial response from families when they show empathy to their emotions.

In a comparison of canagliflozin to other SGLT-2 inhibitors and anti-hyperglycemic therapies, the drug was found to decrease hospitalization from heart failure risk, and carry no extra risk for leg or foot amputation.

This is the only long-acting local anesthetic to demonstrate significantly reduced postoperative pain and opioid use through 72 hours compared to bupivacaine solution for postoperative pain management.

This minimally invasive procedure provides additional options for the patient population suffering with sacral insufficiency fractures.

How history shows us that changing dogma in healthcare practice requires a multi-faceted approach.

Misconceptions linger, and they’re not helping anyone.

Only 6% of respondents said they received any type of financial education during residency, while 79% felt strongly that it should be included in residency education.

Gun violence is an epidemic in the US, but research remains underfunded compared to other leading causes of mortality.

These are the first FDA Premarket Approved stents for stent-assisted coil embolization.

Whether comprised of a nurse anesthetist or anesthesiologist assistant, patients undergoing surgery experienced no significant differences in mortality, length of stay, or inpatient costs.

Of the 246 patients who underwent lung resections, 203 patients had a FEV1 less than 0.8.

Avinger stated that it plans to incorporate this next generation version of the device into its ongoing clinical trial program, INSIGHT, an FDA Investigation Device Exemption study.

From 2000 to 2016, the proportion of organ donors who died of drug intoxication increased from 1.2% to 13.7% in the US.

Results show that blade plates or intramedullary nails placed via surgery can be effective treatments for patients with fibrous dysplasia of the proximal femur.

PLENVU, a one-liter solution from Salix Pharmaceuticals, is expected to reach US markets by the third quarter of 2018.

FusionVu allows for the fastest and simplest real-time targeting of prostate biopsies while also providing the highest resolution in real-time guidance for them, according to Exact Imaging.

The technology can be used with both steam and vaporized hydrogen peroxide, simultaneously in any incubation well.

Two additional implants are added to the current spine labeling.

How an Australian anesthetist and English midwife student convinced providers around the world to be open about their names.

R. Presley Swann, MD discussed his preference for CPNBs when treating his patient's post-operative pain.

Two recent studies on surgical attrition have unveiled the factors that impact dropout rates and timing, highlighting the need for better guidance and early intervention for medical students entering surgical training.

Approximately 1 in every 5 men develop a urinary stricture, with urological procedures pertaining to the treatment anticipated to skyrocket with the aging of the baby boomer generation.

In 90 patients that received idarucizumab in the RE-VERSE AD phase 3 trial, the median maximum percentage reversal was 100%.